Damora Therapeutics (DMRA) Q3 2026 Earnings

5AugConfirmed
Q4 2025
Q1 2026
Q2 2026
Next
-3.24
-1.86
-0.48
0.9

Details

Expected EPS
-0.447003
Actual EPS
N/A
Surprise EPS
0.45
Surprise Percent
+100%

Description

Damora Therapeutics (DMRA) will report earnings of for Q3 2026 on August 05, 2026.

0 Comments

Share your thoughts